ArticleJournal of the National Cancer Institute2023
Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer.
Lynn K Symonds et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.